Letteratura scientifica selezionata sul tema "Maastricht III"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Maastricht III".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Maastricht III"
Sanchez-Izquierdo Riera, J. A., C. Cisneros Alonso, R. García Guijorro, J. C. Montejo González e A. Andrés Belmonte. "Donantes tipo III de Maastricht". Medicina Intensiva 35, n. 8 (novembre 2011): 524–25. http://dx.doi.org/10.1016/j.medin.2011.06.001.
Testo completoClaessen, Jacques, Gwenny Zeles, Sven Zebel e Hans Nelen. "Bemiddeling in strafzaken in Maastricht III". Tijdschrift voor Herstelrecht 15, n. 4 (dicembre 2015): 9–24. http://dx.doi.org/10.5553/tvh/1568654x2015015004003.
Testo completoPerera, M. Thamara P. R. "The super-rapid technique in Maastricht category III donors". Current Opinion in Organ Transplantation 17, n. 2 (aprile 2012): 131–36. http://dx.doi.org/10.1097/mot.0b013e3283510817.
Testo completoLemoine, L., L. Neron, A. Hamidi, A. Leon e J. P. Graftieaux. "Le Maastricht III : une modalité confidentielle de prélèvement d’organes ?" Annales Françaises d'Anesthésie et de Réanimation 33 (settembre 2014): A230. http://dx.doi.org/10.1016/j.annfar.2014.07.388.
Testo completoArnaez, J., F. Gómez e S. Caserío. "Donación en asistolia controlada (tipo III de Maastricht) en pediatría". Medicina Intensiva 41, n. 6 (agosto 2017): 386. http://dx.doi.org/10.1016/j.medin.2016.10.012.
Testo completoArnaez, J., F. Gómez e S. Caserío. "Pediatric donation after controlled cardiac death (Maastricht type III donors)". Medicina Intensiva (English Edition) 41, n. 6 (agosto 2017): 386. http://dx.doi.org/10.1016/j.medine.2016.10.009.
Testo completoBeato Garcia, S., M. Fiol, B. Etcheverry, L. Riera, J. F. Suárez, S. Gil-Vernet e F. Vigués. "Kidneys from Maastricht category III: Does NECMO influence on DGF?" European Urology Supplements 17, n. 2 (marzo 2018): e1756-e1757. http://dx.doi.org/10.1016/s1569-9056(18)32069-4.
Testo completoCorral, E., J. Maynar, I. Saralegui e A. Manzano. "Donantes a corazón parado tipo III de Maastricht: una opción real". Medicina Intensiva 35, n. 1 (gennaio 2011): 59–60. http://dx.doi.org/10.1016/j.medin.2010.09.004.
Testo completoRubio, J. J., e D. Palacios. "Reflections upon donation after controlled cardiac death (Maastricht type iii donors)". Medicina Intensiva (English Edition) 40, n. 7 (ottobre 2016): 431–33. http://dx.doi.org/10.1016/j.medine.2016.04.007.
Testo completoFernandez-Concha Schwalb, J., B. Etcheverry, L. Riera, M. Fiol, X. Bonet, J. F. Suárez, O. Bestard e F. Vigués. "Maastricht III kidneys: Does donor age influence DGF or graft survival?" European Urology Supplements 18, n. 1 (marzo 2019): e1643-e1644. http://dx.doi.org/10.1016/s1569-9056(19)31193-5.
Testo completoTesi sul tema "Maastricht III"
Areal, Calama Juan José. "Viabilitat dels empelts renals provinents de donants en asistòlia controlada (donants tipus III de Maastricht)". Doctoral thesis, Universitat Autònoma de Barcelona, 2018. http://hdl.handle.net/10803/664385.
Testo completoThe national registers document the constant growth of receptors on waiting list for kidney transplant (the vital prognosis of these patients are conditioned by this situation) as well as a certain slowdown of brain death donations. Throughout the country, the potential sources of grafts for transplant have been promoted, especially the living donors and non-heart beating donors. Controlled non-heart-beating donation (CNHBD) presents longer warm ischaemia times wich can affect the viability of the organ, causing a greater delayed function of the graft, immunological phenomena and a lower long term graft survival. At Germans Trias i Pujol University Hospital (HUGTiP), as well as increasing the activity of living donor transplantation, a program of Controlled non-heart-beating donation Maastricht III type was launched in October 2014. This retrospective work (over three years of program) studies the viability of grafts and receptors after CNHBD, recording parameters such as primary graft non-function, delayed graft function, evolution of functional parameters, acute rejection, graft survival, patients survival and complications. We also analyze what factors of the recipient, the donor and the act of the transplant have significantly influenced the viability of grafts and patients. In the HUGTiP series, the primary failure of the graft and the mortality of patients is slightly higher than that of the national groups, probably due to the smaller sample size. The delayed graft function is 10-20% better and the evolution of the functional parameters is slightly better. Unlike the national groups, no functioning graft was lost among the live receptors during the follow up. There is a large majority of patients with no major surgical complications and an acceptable rejection rate. The results so far endorse the suitability of the CNHBD program at HUGTiP.
Manciño, Contreras José María. "Implementación de un programa de donación en asistolia controlada tipo III de maastricht en el Hospital Germans Trias i Pujol". Doctoral thesis, Universitat Autònoma de Barcelona, 2019. http://hdl.handle.net/10803/669641.
Testo completoOur country has been a world leader in donation and transplants uninterruptedly for 27 years. However, organ shortages remains a limiting factor to cover the transplanting needs. A negative trend in the number of donation after brain death (DBD) was observed in the middle of the past decade, and The Organización Nacional de Trasplantes (ONT) in 2008 it launched a national strategic plan, the so-called "Plan Donación Cuarenta”, which aimed to improve donation rates, by developing new programs of donation after circulatory death (DCD). Our centre's Transplant Coordination Team implemented a Type III DCD programme which commenced on October 14, 2014. The creation of such a program has an interest in both the donor generation process and the results of transplanted grafts from these donors. The DCD donors have been considered as donors with expanded criteria, where ischemia times are relevant for the subsequent functioning of transplanted grafts. We carried out a two-phase observational study. The first, retrospective, comprising the previous two years before Type III DCD programme started, and a prospective phase which included the two years following the onset of the programme. In both phase we analysed the potential Type III DCD, the DBD donors generated at our center, as well as kidney transplants performed from kidneys generated in our centre. Also, in the second phase, we recorded all the DCD donors. The onset of the controlled DCD type III programme in our hospital has led to a 124% increase in the activity of the deceased donation valid for the renal transplant program, an increase of 112% in the number of kidneys valid for transplantation (43% of the kidneys were generated from type III donors), and an 89% increase in renal graft transplant activity from donors generated at our center. Contrasting the results with those published in the national series, effectiveness in the donation process, effective renal donation and the percentage of renal use of type III donors were higher in our series than in the national series. The number of type III donors obtained was expected according to the forecast established in the first study period. The DBD activity was increased by 13%, so the inauguration of the program had a positive impact on DBD donors. The rates of family refusals to the donation presented similar rates in both study periods and similar to the national series, so the program seems not to have influenced family decision-making. No association was found between delayed graft function (DGF) and other variables such as cold ischemia time, hot ischemic time or donor or recipient age. The DGF in our series compared to the national series showed lower percentages without statistical significance. Regarding renal transplant results, only the donor's smoking habit showed association with increased DGF. Although the cold ischemia time of type III donors was clearly lower than DBD donors, it showed no association with the DGF.
Le, Dorze Matthieu. "Les facultés éthiques des réanimateurs, l'ajustement et l'alignement". Electronic Thesis or Diss., université Paris-Saclay, 2024. http://www.theses.fr/2024UPASR033.
Testo completoIn routine daily practice, intensive care physicians are involved in end-of-life care. Their end-of-life decisions and practices are highly complex, involving many people (patient, relatives, and caregivers), a variety of medical and non-medical factors, and often a number of unknowns and uncertainties.The aim of this work is to describe and analyze this complexity with a view to highlighting, throw a normative approach, the ethical faculties that intensive care physicians could use to act well or at least as well as possible. This work is based on three methodological approaches: individual experience, group discussion, and a multidisciplinary scientific approach that includes surveys as well as quantitative and qualitative research. It is based on two different areas of research: The definition of “unreasonable obstinacy”, continuous deep sedation and the declaration of death in the everyday context of end-of-life in intensive care, and how these are reshaped in relation to the specific issue of controlled donation after circulatory death. This ethical process, based on the practical realities of clinical situations, provides the basis for two skills - fit and line. These skills are developed and improved step by step. It is only through organisations concerned with the development of a peaceful ethical climate that intensive care physicians will be able to use these skills to positively address the tensions associated with end-of-life care and organ donation as a subject of ongoing ethical creativity
Libri sul tema "Maastricht III"
Ferrandis, Fernando Fonseca. Implicaciones jurídico-administrativas de la donación a corazón parado; a propósito del protocolo tipo III de maastricht. Aranzadi, 2019.
Cerca il testo completoCano, Marta Riquelme, Raquel Alcaide Jiménez e Cristina Palazón Carpe. Aspectos ético-legales de la donación de órganos en asistolia controlada tipo iii de la escala de maastricht. Bubok Publishing, 2020.
Cerca il testo completoIci Maastricht!: Les Européens parlent aux Européens! Le Monde-Editions, 1992.
Cerca il testo completoProceedings of the 2nd International Digital Congress on 3D Biofabrication and Bioprinting (3DBB) - Biofabrication, Bioprinting, Additive Manufacturing applied to health. Editora Realize, 2022. http://dx.doi.org/10.46943/ii.3dbb.2022.01.000.
Testo completoCapitoli di libri sul tema "Maastricht III"
Lößlein, Horst. "Les ressources en compétition : les conflits concernant Saint-Vaast et Saint-Servais de Maastricht entre les grands et Charles III « le Simple »". In Haut Moyen Âge, 207–26. Turnhout: Brepols Publishers, 2017. http://dx.doi.org/10.1484/m.hama-eb.5.112179.
Testo completoThomas, Anja. "CHAPTER III 1979-99 – The Maastricht period – Acting Europe". In Assemblée Nationale, Bundestag and the European Union, 94–151. Nomos Verlagsgesellschaft mbH & Co. KG, 2019. http://dx.doi.org/10.5771/9783845290294-94.
Testo completoArnull, Anthony. "The free movement of workers". In The European Union and its Court of Justice, 441–61. Oxford University PressOxford, 2006. http://dx.doi.org/10.1093/oso/9780199258840.003.0012.
Testo completoHoyer, Werner. "Von Maastricht nach Amsterdam:". In Maastricht II - Entwicklungschancen und Risiken der EU: Erweiterung, Vertiefung oder Stagnation?, 9–29. Duncker & Humblot, 2019. http://dx.doi.org/10.2307/j.ctv2k88hvf.4.
Testo completoDumke, Rolf H. "Historische Erfahrung und theoretische Erkenntnisse zur Frage einer Harmonisierung der Finanz- und Lohnpolitik und eines europaweiten Finanzausgleichs in der europäischen Währungsunion." In Maastricht II - Entwicklungschancen und Risiken der EU: Erweiterung, Vertiefung oder Stagnation?, 213–22. Duncker & Humblot, 2019. http://dx.doi.org/10.2307/j.ctv2k88hvf.16.
Testo completo"Zusammenfassung der Diskussion". In Maastricht II - Entwicklungschancen und Risiken der EU: Erweiterung, Vertiefung oder Stagnation?, 168–80. Duncker & Humblot, 2019. http://dx.doi.org/10.2307/j.ctv2k88hvf.14.
Testo completoSchmidt, Ingo. "Wettbewerbspolitik versus Industriepolitik in der EG." In Maastricht II - Entwicklungschancen und Risiken der EU: Erweiterung, Vertiefung oder Stagnation?, 59–67. Duncker & Humblot, 2019. http://dx.doi.org/10.2307/j.ctv2k88hvf.7.
Testo completoGabrisch, Hubert. "Gesamtwirtschaftliche Anpassungsprozesse in mittel- und osteuropäischen Ländern nach einem Beitritt zur EU". In Maastricht II - Entwicklungschancen und Risiken der EU: Erweiterung, Vertiefung oder Stagnation?, 123–56. Duncker & Humblot, 2019. http://dx.doi.org/10.2307/j.ctv2k88hvf.12.
Testo completo"Teilnehmerverzeichnis der 59. Jahrestagung (wissenschaftlicher Teil)". In Maastricht II - Entwicklungschancen und Risiken der EU: Erweiterung, Vertiefung oder Stagnation?, 238–40. Duncker & Humblot, 2019. http://dx.doi.org/10.2307/j.ctv2k88hvf.18.
Testo completoSchweickert, Rainer. "Harmonisierung versus institutioneller Wettbewerb zur Sicherung realwirtschaftlicher Anpassung und monetärer Stabilität in der Europäischen Währungsunion". In Maastricht II - Entwicklungschancen und Risiken der EU: Erweiterung, Vertiefung oder Stagnation?, 181–212. Duncker & Humblot, 2019. http://dx.doi.org/10.2307/j.ctv2k88hvf.15.
Testo completoAtti di convegni sul tema "Maastricht III"
ORGA-DUMITRIU, Gina. "CAPITAL MOVEMENTS VS. FREEDOM OF ESTABLISHMENT AND FREEDOM TO PROVIDE SERVICES IN THE CASE-LAW OF THE CJEU". In 10th SWS International Scientific Conferences on SOCIAL SCIENCES - ISCSS 2023. SGEM WORLD SCIENCE, 2023. http://dx.doi.org/10.35603/sws.iscss.2023/s02.02.
Testo completo